End stage renal disease (ESRD) is chronic inflammatory condition which affects iron parameters. Serum soluble transferrin receptor (sTfR) is a

Recent studies suggest the possibility of activating immune mechanism in the onset and progression of atherosclerotic disease. The aim of

The reliability of haemoglobin A1c (HbA1c) as a glycaemic marker in patients receiving haemodialysis (HD) remains unknown. To assess accuracy,

Post-transplant hypercalcemia is common after successful kidney transplantation in patients with chronic kidney disease (CKD) and can be partially explained

IgA nephropathy (IgAN) is the most common primary glomerulonephritis globally and an important cause of chronic kidney disease (CKD). Up

Dapagliflozin is an inhibitor of sodiumdependent glucose transporters 2, which is a new drug for diabetes mellitus. Recent researches indicated

Chronic kidney disease (CKD) continues to be a growing health concern worldwide, with an estimated global prevalence of 9.1% in

Sodium-glucose co-transporter 2 (SGLT2) inhibitors, the most recent glucose lowering oral agents, prevent glucose and sodium reabsorption at proximal tubules.

The emergence of positive data on the use of sodium glucose co-transporter inhibitors (SGLT2i) in the last several years, begged

Serum uric acid may predict the onset and progression of kidney disease, and the occur- rence of cardiovascular (CVM) and